Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function
- PMID: 2203304
- PMCID: PMC171772
- DOI: 10.1128/AAC.34.6.1139
Interactions of ceftazidime and tobramycin in patients with normal and impaired renal function
Abstract
We studied the in vivo interaction of ceftazidime and tobramycin in normal volunteers and anuric patients given each drug separately or both drugs in combination. Kinetic analysis of plasma concentration data showed minor changes in the disposition of these agents when they were given concurrently. However, the resulting clearance of both tobramycin and ceftazidime was unchanged when these drugs were given concurrently. The volume of distribution of tobramycin at steady state was increased by 20% in normal volunteers when given with ceftazidime. The increase in distribution was accompanied by a slight decrease in ceftazidime elimination rate. No additional alteration in dosing over those necessary to adjust for a decrease in renal function is necessary when giving this combination.
Similar articles
-
Use of pharmacodynamic parameters to predict efficacy of combination therapy by using fractional inhibitory concentration kinetics.Antimicrob Agents Chemother. 1998 Apr;42(4):744-8. doi: 10.1128/AAC.42.4.744. Antimicrob Agents Chemother. 1998. PMID: 9559776 Free PMC article.
-
Synergism between tobramycin and ceftazidime against a resistant Pseudomonas aeruginosa strain, tested in an in vitro pharmacokinetic model.Antimicrob Agents Chemother. 1997 Jan;41(1):95-100. doi: 10.1128/AAC.41.1.95. Antimicrob Agents Chemother. 1997. PMID: 8980762 Free PMC article.
-
Interactions of moxalactam and tobramycin in normal volunteers and in patients with impaired renal function.J Infect Dis. 1984 Jan;149(1):9-15. doi: 10.1093/infdis/149.1.9. J Infect Dis. 1984. PMID: 6693791
-
Review of Clinical Pharmacokinetics of Avibactam, A Newly Approved non-β lactam β-lactamase Inhibitor Drug, In Combination Use With Ceftazidime.Drug Res (Stuttg). 2019 May;69(5):245-255. doi: 10.1055/a-0748-5548. Epub 2018 Oct 8. Drug Res (Stuttg). 2019. PMID: 30296806 Review.
-
Clinical Pharmacokinetics and Pharmacodynamics of Ceftazidime-Avibactam Combination: A Model-Informed Strategy for its Clinical Development.Clin Pharmacokinet. 2019 May;58(5):545-564. doi: 10.1007/s40262-018-0705-y. Clin Pharmacokinet. 2019. PMID: 30097887 Review.
Cited by
-
Lack of pharmacokinetic interaction between cefepime and amikacin in humans.Antimicrob Agents Chemother. 1992 Jul;36(7):1382-6. doi: 10.1128/AAC.36.7.1382. Antimicrob Agents Chemother. 1992. PMID: 1510431 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases